NPASS Compound

Structure

NPC105798 OpenBabel06302215412D 40 44 0 0 1 0 0 0 0 0999 V2000 2.1370 -3.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1370 -3.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6370 -4.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6370 -2.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3630 -2.6883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1370 -1.8223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6370 -0.9562 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.1370 -0.0902 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.6370 0.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3630 0.7758 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.8630 1.6418 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.8630 2.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8630 1.6418 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.3630 2.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3630 0.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8630 -0.0902 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.8630 -0.0902 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.3630 -0.9562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8630 -1.8223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3630 -2.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8630 -3.5543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3630 -2.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3630 -0.9562 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.2290 -1.4562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3630 -1.9562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3630 -0.9562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8630 -1.8223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8630 -1.8223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3630 -2.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0031 2.1418 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.9166 1.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5857 2.4782 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.5639 2.6862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6684 3.6807 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.0000 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7549 4.0874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0857 3.3443 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.1076 3.1364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1370 -0.0902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 7 6 1 6 0 0 0 7 8 1 0 0 0 0 7 23 1 0 0 0 0 8 9 1 0 0 0 0 8 40 1 1 0 0 0 10 9 1 1 0 0 0 10 11 1 0 0 0 0 10 17 1 0 0 0 0 11 12 1 1 0 0 0 11 13 1 0 0 0 0 11 30 1 0 0 0 0 13 14 1 1 0 0 0 13 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 16 26 1 1 0 0 0 17 18 1 1 0 0 0 17 23 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 20 21 2 0 0 0 0 20 22 1 0 0 0 0 23 25 1 0 0 0 0 23 24 1 6 0 0 0 24 25 1 0 0 0 0 26 27 1 0 0 0 0 27 28 2 0 0 0 0 27 29 1 0 0 0 0 30 31 1 1 0 0 0 30 39 1 0 0 0 0 32 31 1 6 0 0 0 32 33 1 0 0 0 0 32 38 1 0 0 0 0 33 34 1 0 0 0 0 34 35 1 1 0 0 0 34 37 1 0 0 0 0 35 36 1 0 0 0 0 38 37 1 6 0 0 0 38 39 1 0 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	568.29
Volume:	556.141
LogP:	2.473
LogD:	2.245
LogS:	-4.451
# Rotatable Bonds:	10
TPSA:	139.35
# H-Bond Aceptor:	11
# H-Bond Donor:	1
# Rings:	5
# Heavy Atoms:	11

MedChem Properties

QED Drug-Likeness Score:	0.275
Synthetic Accessibility Score:	6.009
Fsp3:	0.897
Lipinski Rule-of-5:	Rejected
Pfizer Rule:	Accepted
GSK Rule:	Rejected
BMS Rule:	1
Golden Triangle Rule:	Rejected
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-5.277
MDCK Permeability:	0.00011601366713875905
Pgp-inhibitor:	0.987
Pgp-substrate:	0.974
Human Intestinal Absorption (HIA):	0.002
20% Bioavailability (F20%):	0.019
30% Bioavailability (F30%):	0.13

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.056
Plasma Protein Binding (PPB):	35.454383850097656%
Volume Distribution (VD):	1.195
Pgp-substrate:	46.456787109375%

ADMET: Metabolism

CYP1A2-inhibitor:	0.003
CYP1A2-substrate:	0.099
CYP2C19-inhibitor:	0.012
CYP2C19-substrate:	0.681
CYP2C9-inhibitor:	0.009
CYP2C9-substrate:	0.01
CYP2D6-inhibitor:	0.021
CYP2D6-substrate:	0.089
CYP3A4-inhibitor:	0.573
CYP3A4-substrate:	0.727

ADMET: Excretion

Clearance (CL):	3.499
Half-life (T1/2):	0.785

ADMET: Toxicity

hERG Blockers:	0.435
Human Hepatotoxicity (H-HT):	0.466
Drug-inuced Liver Injury (DILI):	0.847
AMES Toxicity:	0.474
Rat Oral Acute Toxicity:	0.153
Maximum Recommended Daily Dose:	0.211
Skin Sensitization:	0.425
Carcinogencity:	0.106
Eye Corrosion:	0.004
Eye Irritation:	0.027
Respiratory Toxicity:	0.944

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC105798

Natural Product ID:	NPC105798
*Common Name:**	NGGYLLJIBWFQCM-CPXBAMRFSA-N
IUPAC Name:	n.a.
Synonyms:
Standard InCHIKey:	NGGYLLJIBWFQCM-CPXBAMRFSA-N
Standard InCHI:	InChI=1S/C29H44O11/c1-14(2)25(33)40-24-19(32)11-20-27(6,21-9-18-10-23(34-7)39-26(18)38-21)15(3)8-22(37-17(5)31)28(20,12-35-16(4)30)29(24)13-36-29/h14-15,18-24,26,32H,8-13H2,1-7H3/t15-,18+,19-,20-,21+,22+,23-,24+,26-,27+,28+,29-/m1/s1
SMILES:	CC(C)C(=O)O[C@H]1[C@@H](C[C@@H]2[C@](C)([C@H](C)C[C@@H]([C@@]2(COC(=O)C)[C@]21CO2)OC(=O)C)[C@@H]1C[C@H]2C[C@H](OC)O[C@H]2O1)O
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	n.a.
PubChem CID:	10721736
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000264] Organic acids and derivatives [CHEMONTID:0000265] Carboxylic acids and derivatives [CHEMONTID:0001986] Tricarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO18973	Ajuga pseudoiva	Species	Lamiaceae	Eukaryota	leaves	Tunisian	n.a.	PMID[10727804]
NPO18973	Ajuga pseudoiva	Species	Lamiaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
Others	4

Activity Type	# Activity
Organism	4

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT776	Organism	Spodoptera littoralis	Spodoptera littoralis	AFI	=	37.3	%	PMID[494765]
NPT776	Organism	Spodoptera littoralis	Spodoptera littoralis	AFI	=	63.3	%	PMID[494765]
NPT776	Organism	Spodoptera littoralis	Spodoptera littoralis	AFI	=	100.0	%	PMID[494765]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC105798 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score	Similarity Level	Natural Product ID

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC105798 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score	Similarity Level	Drug ID	Developmental Stage

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data